Baseline characteristics, the Bangladesh HEARTS trial*
| Characteristic | Total | Intervention | Usual care | Test | P value |
| Number | 3935 | 1950 | 1985 | Not applicable | |
| Female | 2775 (70.5) | 1350 (69.2) | 1425 (71.8) | χ2 | 0.079 |
| Age (years) | 52.3 (12.4) | 53.3 (12.2) | 51.3 (12.5) | Two-sample t-test | <0.001 |
| Diagnosis of diabetes | 526 (13.4) | 378 (19.4) | 148 (7.5) | χ2 | <0.001 |
| Prior heart attack | 20 (0.5) | 10 (0.5) | 10 (0.5) | Fisher’s exact | >0.99 |
| Prior stroke | 36 (0.9) | 19 (1.0) | 17 (0.9) | Fisher’s exact | 0.74 |
| Prior CKD | 6 (0.2) | 3 (0.2) | 3 (0.2) | Fisher’s exact | >0.99 |
| Baseline HTN medication use | 3164 (80.4) | 1798 (92.2) | 1366 (68.8) | χ2 | <0.001 |
| Baseline SBP (mm Hg) | 158.6 (15.2) | 158.4 (15.0) | 158.8 (15.4) | Two-sample t-test | 0.48 |
| Baseline DBP (mm Hg) | 92.3 (10.3) | 92.3 (10.2) | 92.2 (10.3) | Two-sample t-test | 0.86 |
Those with ‘unknown’ for prior disease history were assumed to have no relevant disease history.
*Data are presented as mean (SD) for continuous measures, and n (%) for categorical measures.
CKD, chronic kidney disease; DBP, diastolic blood pressure; HTN, hypertension; SBP, systolic blood pressure.